RankAlpha logo
Back to Rankings

LGVN

LongeveronF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
LGVN vs peer average
26/100
LGVN vs. peer average (F vs. C)
Grade spread
A 1 · B 2 · D 2 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CLRB is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $20.06M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCLRBCellectar Biosciences
LGVN
Longeveron
CLRB
Cellectar Biosciences
Grade
F
B
Momentum
12
69
Value
41
41
Sentiment
-
65
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs CLRB

LGVN / CLRB
Grade Position
Below peers
LGVN vs. peer average (F vs. C)
26/100
Momentum
12
CLRB
Value
41
LGVN
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs LGVN
1
CLRB
Cellectar Biosciences Inc Common
B
80/100
-3
2
PLUR
Pluri Inc Common
D
40/100
-1
3
ALLR
Allarity Therapeutics Inc Common
F
20/100
Even
4
QNTM
Quantum Biopharma Ltd Subordinate Voting Shares Class B Common
D
40/100
-1
5
ZYBT
Zhengye Biotechnology Holding Ltd Class A Common
B
80/100
-3
CLRB is the first peer returned for this comparison set.